Author: D'Amico, Francesca; Mukhopadhyay, Rishov; Ovaa, Huib; Mulder, Monique P. C.
Title: Targeting TRIM Proteins: A Quest towards Drugging an Emerging Protein Class Cord-id: 0eur5iyo Document date: 2021_3_18
ID: 0eur5iyo
Snippet: The ubiquitylation machinery regulates several fundamental biological processes from protein homeostasis to a wide variety of cellular signaling pathways. As a consequence, its dysregulation is linked to diseases including cancer, neurodegeneration, and autoimmunity. With this review, we aim to highlight the therapeutic potential of targeting E3 ligases, with a special focus on an emerging class of RING ligases, named triâ€partite motif (TRIM) proteins, whose role as targets for drug developmen
Document: The ubiquitylation machinery regulates several fundamental biological processes from protein homeostasis to a wide variety of cellular signaling pathways. As a consequence, its dysregulation is linked to diseases including cancer, neurodegeneration, and autoimmunity. With this review, we aim to highlight the therapeutic potential of targeting E3 ligases, with a special focus on an emerging class of RING ligases, named triâ€partite motif (TRIM) proteins, whose role as targets for drug development is currently gaining pharmaceutical attention. TRIM proteins exert their catalytic activity as scaffolds involved in many protein–protein interactions, whose multidomains and adapterâ€like nature make their druggability very challenging. Herein, we give an overview of the current understanding of this class of single polypeptide RING E3 ligases and discuss potential targeting options.
Search related documents:
Co phrase search for related documents, hyperlinks ordered by date